-
Stock Market
Fairmount Healthcare Fund II LP buys $5.1m of Zenas BioPharma stock By Investing.com
In a series of recent transactions, Fairmount Healthcare Fund II LP significantly increased its stake in Zenas BioPharma, Inc. (NASDAQ:ZBIO),…
Read More » -
Real State
Kentucky Housing Commissions: What to Expect in 2024
Understanding the details of real estate commissions is important when buying or selling a home in Kentuckyas it plays a…
Read More » -
Insurance
Key Insights from the CoreLogic® Wildfire Risk 2024 report
This post is part of a series sponsored by CoreLogic. August 8, 2024, marked one year since the Lahaina Fires…
Read More » -
Real State
Banks Face Pressure to Fund Affordable Housing Projects, Opening Up Opportunities for Investors
In this article Key Takeaways Federal loan lenders have expressed concern that expanding their contributions to affordable housing, as proposed…
Read More » -
Savings
Apple iPad (9th generation) only $199 shipped!
Hey! This is an amazing deal on this Apple iPad (9th Generation)! Amazon has this Apple iPad (9th generation) in…
Read More » -
Savings
Get a free National Trust Day Pass worth £35
For a short period, you can claim a free National Trust pass worth around £35 to use at sites across…
Read More » -
Real State
Keller Williams is settling some lawsuits related to its profit-sharing plan
Keller Williams‘ legal worries have become easier. On Friday, the landlord and the plaintiffs’ attorney in the McFarlane case reached…
Read More » -
Loan
Mortgage Rates Could Drop Another Half Point in Market Stabilization
It’s been a great year so far for mortgage rates, which are up nearly 8% over the past year. The…
Read More » -
Stock Market
Where will Tesla’s share price be 5 years from now?
Image source: Getty Images Back in June, ARK Invest suggested that Tesla (NASDAQ:TSLA) price could reach $2,600 in 2029. Most…
Read More » -
Stock Market
Bicycle Therapeutics Stock Maintains Buy Rating at HC Wainwright in Strong Research Results Via Investing.com
HC Wainwright reaffirmed its buy rating and $55.00 price target on Bicycle Therapeutics (NASDAQ: NASDAQ: ), following a review of…
Read More »